Detection of Clostridium perfringens Using Novel Methods Based on Recombinase-Aided Amplification Assay-Assisted CRISPR/Cas12a System
Transboundary and Emerging Diseases · 2023
DOI: 10.1155/2023/6667618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, 2023. Verfasst von Xingxing Xiao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life…. Hauptthemen laut MEDLINE: Clostridium perfringens, CRISPR-Cas Systems, Clostridium Infections, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, University-Industry Collaborative Education Program, Key Discipline of Zhejiang Province in Medical Technology.
Abstract (Originalsprache)
Clostridium perfringens is a highly versatile pathogen of humans and animals. Rapid and sensitive detection methods for C. perfringens are urgently needed for the timely implementation of control. In this study, to provide novel promising methods for the detection of C. perfringens, two rapid, sensitive, and instrument-free C. perfringens detection methods based on recombinase-aided amplification (RAA) assay and clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 12a (CRISPR/Cas12a) system were developed depending on fluorescence signal (RAA-CRISPR/Cas12a-FL) and lateral flow strip (RAA-CRISPR/Cas12a-LFS), respectively. The limit of detection of the RAA-CRISPR/Cas12a-FL and RAA-CRISPR/Cas12a-LFS methods is 2 copies and 20 copies of C. perfringens genomic DNA per reaction, respectively, and the whole process can be completed in 1 hr. Moreover, these two methods show no cross-reactivity with nontarget bacteria, which were used as a negative control to evaluate the specificity of two developed methods in the detection of C. perfringens and have 100% consistent with real-time polymerase chain reaction tests for 12 clinical samples collected from 2 Chinese Milu at Beijing Milu Ecological Research Center and 6 spiked samples from human blood and stool. Overall, the constructed C. perfringens detection methods, RAA-CRISPR/Cas12a-FL and RAA-CRISPR/Cas12a-LFS, have great potential as a novel detection scheme for the early diagnosis of C. perfringens infection in humans and animals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
- Beijing Milu Ecological Research Center, Beijing Academy of Science and Technology, Beijing 100076, China.
- National Research Center for Wildlife-Born Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
- Zhuji Institute of Biomedicine, Wenzhou Medical University, Zhuji, Shaoxing, Zhejiang 311800, China.
ORCID-Profile: Qingxun Zhang, Hongxuan He, Jiade Bai, Yongliang Lou
Förderung
- Natural Science Foundation of Zhejiang Province
- University-Industry Collaborative Education Program
- Key Discipline of Zhejiang Province in Medical Technology
Zitieren
APA
Xiao, X., Zhang, Q., Wu, S., Li, Y., Zhong, Z., Guo, Q., Li, J., Meng, Q., Cheng, Z., Duan, J., Wang, X., He, H., Bai, J., & Lou, Y. (2023). Detection of Clostridium perfringens Using Novel Methods Based on Recombinase-Aided Amplification Assay-Assisted CRISPR/Cas12a System. Transboundary and Emerging Diseases. https://doi.org/10.1155/2023/6667618
Vancouver
Xiao X, Zhang Q, Wu S, Li Y, Zhong Z, Guo Q, et al. Detection of Clostridium perfringens Using Novel Methods Based on Recombinase-Aided Amplification Assay-Assisted CRISPR/Cas12a System. Transboundary and Emerging Diseases. 2023. doi:10.1155/2023/6667618
BibTeX
@article{Xiao2023,
author = {Xiao, Xingxing and Zhang, Qingxun and Wu, Sihong and Li, Yi and Zhong, Zhenyu and Guo, Qingyun and Li, Junfang and Meng, Qinghui and Cheng, Zhibin and Duan, Jianbin and Wang, Xiaoqiong and He, Hongxuan and Bai, Jiade and Lou, Yongliang},
title = {Detection of Clostridium perfringens Using Novel Methods Based on Recombinase-Aided Amplification Assay-Assisted CRISPR/Cas12a System},
journal = {Transboundary and Emerging Diseases},
year = {2023},
doi = {10.1155/2023/6667618}
}
EUVIMED